What biopharma companies need to know about this evolving regulatory pathway.
Cori Gorman, PhD
Advertisement
Senior director, biopharmaceutical CMC and regulatory affairs, Cencora
Articles by Cori Gorman, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
President Trump Announces Nine More TrumpRx Participants
2
Eli Lilly Announces Topline Results From Phase III Trial Studying Oral GLP-1 Therapy Orforglipron
3
BioMarin Reaches $4.8 Billion Definitive Agreement to Acquire Amicus Therapeutics
4
Novo Nordisk Submits NDA to FDA for CagriSema
5